Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Algorae Pharmaceuticals Limited (LHI0.F) Follow Compare 0.0010 0.0000 (0.00%) At close: March 11 at 8:29:26 AM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations ASX Penny Stock Spotlight Algorae Pharmaceuticals And Two More Companies The Australian market has recently experienced a downturn, with the ASX 200 setting a new 20-day low, influenced by global trade uncertainties and flat commodity prices. Despite these challenges, certain investment opportunities remain appealing, particularly in sectors like Utilities and Health Care that have shown resilience. Penny stocks may seem like an outdated concept, but they continue to offer potential for growth at lower price points when backed by strong financials. In this... 3 Promising ASX Penny Stocks With Market Caps Up To A$40M As the Australian market navigates a cautious atmosphere, with eyes on retail sales figures and interest rate speculations, investors are keenly assessing opportunities amid fluctuating conditions. Penny stocks, often associated with smaller or emerging companies, continue to attract attention for their potential to offer growth at lower price points. When backed by robust financial health, these stocks can present compelling opportunities for those looking beyond traditional investment avenues. ASX Penny Stocks To Watch In November 2024 The Australian market has experienced a downturn, with the ASX200 closing down 0.35% at 8266 points, as investors reacted to underwhelming Chinese stimulus measures and subsequent declines in commodity prices. In this context, identifying promising investment opportunities requires careful consideration of market dynamics and sector performance. While the term "penny stock" may seem outdated, it still signifies smaller or newer companies that can offer substantial value when backed by strong... One Algorae Pharmaceuticals Insider Raised Their Stake In The Previous Year Looking at Algorae Pharmaceuticals Limited's ( ASX:1AI ) insider transactions over the last year, we can see that... Performance Overview Trailing total returns as of 3/12/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] Return LHI0.F S&P/ASX 200 [XJO] YTD -33.33% -4.82% 1-Year -50.00% +0.47% 3-Year -85.71% +9.95%